These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30998810)

  • 21. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
    Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential predictive markers in protocol biopsies for premature renal graft loss.
    Matl I; Hribova P; Honsova E; Brabcova I; Viklicky O
    Kidney Blood Press Res; 2010; 33(1):7-14. PubMed ID: 20090361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of sentinel flaps in assessing facial allograft rejection.
    Kueckelhaus M; Fischer S; Lian CG; Bueno EM; Marty FM; Tullius SG; Pribaz JJ; Murphy GJ; Pomahac B
    Plast Reconstr Surg; 2015 Jan; 135(1):250-258. PubMed ID: 25255116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Face transplantation: A longitudinal histological study focusing on chronic active and mucosal rejection in a series with long-term follow-up.
    Moktefi A; Hivelin M; Grimbert P; Carmagnat M; Sbidian E; Papouin B; Suberbielle C; Wolkenstein P; Bosc R; Meningaud JP; Lantieri L; Ortonne N
    Am J Transplant; 2021 Sep; 21(9):3088-3100. PubMed ID: 33445219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation.
    Vitulo P; Oggionni T; Cascina A; Arbustini E; D'Armini AM; Rinaldi M; Meloni F; Rossi A; Viganò M
    J Heart Lung Transplant; 2002 Apr; 21(4):435-9. PubMed ID: 11927219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of increasing baseline immunosuppression on the prevalence of clinical and subclinical rejection: a pilot study.
    Nickerson P; Jeffery J; Gough J; Grimm P; McKenna R; Birk P; Rush D
    J Am Soc Nephrol; 1999 Aug; 10(8):1801-5. PubMed ID: 10446949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of surveillance biopsies in infant heart transplant recipients.
    Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH; Laskow D; Deierhoi MH; Burdick J; Pirsch JD; Sollinger H; Vincenti F; Burrows L; Schwartz B; Danovitch GM; Wilkinson AH; Shaffer D; Simpson MA; Freeman RB; Rohrer RJ; Mendez R; Aswad S; Munn SR; Wiesner RH; Delmonico FL; Neylan J; Whelchel J
    Transplantation; 1996 Sep; 62(5):594-9. PubMed ID: 8830821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single center experience of abdominal wall graft rejection after combined intestinal and abdominal wall transplantation.
    Allin BS; Ceresa CD; Issa F; Casey G; Espinoza O; Reddy S; Sinha S; Giele H; Friend P; Vaidya A
    Am J Transplant; 2013 Aug; 13(8):2211-5. PubMed ID: 23837458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathologic characteristics of human intestine allograft acute rejection in patients pretreated with thymoglobulin or alemtuzumab.
    Wu T; Bond G; Martin D; Nalesnik MA; Demetris AJ; Abu-Elmagd K
    Am J Gastroenterol; 2006 Jul; 101(7):1617-24. PubMed ID: 16863569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical rejection in tacrolimus-treated renal transplant recipients.
    Gloor JM; Cohen AJ; Lager DJ; Grande JP; Fidler ME; Velosa JA; Larson TS; Schwab TR; Griffin MD; Prieto M; Nyberg SL; Sterioff S; Kremers WK; Stegall MD
    Transplantation; 2002 Jun; 73(12):1965-8. PubMed ID: 12131699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yield of surveillance transbronchial biopsies performed beyond two years after lung transplantation.
    Kesten S; Chamberlain D; Maurer J
    J Heart Lung Transplant; 1996 Apr; 15(4):384-8. PubMed ID: 8732597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
    Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
    J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients.
    Wang XZ; Jin ZK; Tian XH; Xue WJ; Tian PX; Ding XM; Zheng J; Li Y; Jing X; Luo ZZ
    Transpl Immunol; 2014 Jan; 30(1):18-23. PubMed ID: 24211610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological Findings of Chronic Rejection in a Face Grafted Patient.
    Petruzzo P; Kanitakis J; Testelin S; Pialat JB; Buron F; Badet L; Thaunat O; Devauchelle B; Morelon E
    Transplantation; 2015 Dec; 99(12):2644-50. PubMed ID: 25989498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.